Testing for HLA/peptide tetramer-binding to the T cell receptor complex on human T lymphocytes.

about

Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer.

P2860

Q37741161-46D92CAA-AE3B-40DD-83A7-16BEBC92A88F

P2860

Testing for HLA/peptide tetramer-binding to the T cell receptor complex on human T lymphocytes.

Item

http://www.wikidata.org/entity/Q42796696

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Testing for HLA/peptide tetram ...... omplex on human T lymphocytes.

@en

Testing for HLA/peptide tetram ...... omplex on human T lymphocytes.

@nl

type

Item

label

Testing for HLA/peptide tetram ...... omplex on human T lymphocytes.

@en

Testing for HLA/peptide tetram ...... omplex on human T lymphocytes.

@nl

prefLabel

Testing for HLA/peptide tetram ...... omplex on human T lymphocytes.

@en

Testing for HLA/peptide tetram ...... omplex on human T lymphocytes.

@nl

P1476

Testing for HLA/peptide tetram ...... complex on human T lymphocytes

@en

P2093

Hergen Spits

http://www.w3.org/2001/XMLSchema#string

Pauline Weder

http://www.w3.org/2001/XMLSchema#string

P2860

Phenotypic analysis of antigen-specific T lymphocytes

Melan-A/MART-1(51-73) represents an immunogenic HLA-DR4-restricted epitope recognized by melanoma-reactive CD4(+) T cells.

Naturally occurring human lymphocyte antigen-A2 restricted CD8+ T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients.

Precision and linearity targets for validation of an IFNgamma ELISPOT, cytokine flow cytometry, and tetramer assay using CMV peptides.

CD4(+) T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele: association with NY-ESO-1 antibody production.

Anti-CD8 antibodies can trigger CD8+ T cell effector function in the absence of TCR engagement and improve peptide-MHCI tetramer staining.

Quantitating cellular immune responses to cancer vaccines.

Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses.

Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4(+) T lymphocytes.

Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes.

P304

88-96

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.RINIM.2012.04.001

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rosalie M Luiten

Ton N Schumacher

P577

2012-05-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257741404

http://www.w3.org/2001/XMLSchema#string

P698

24371571

http://www.w3.org/2001/XMLSchema#string

P932

3862383

http://www.w3.org/2001/XMLSchema#string

Testing for HLA/peptide tetramer-binding to the T cell receptor complex on human T lymphocytes.

about

P2860

P2860

Testing for HLA/peptide tetramer-binding to the T cell receptor complex on human T lymphocytes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P932